OR WAIT null SECS
May 23, 2018
The new company will develop proprietary RNA-based therapeutics and will provide broad lentiviral development and manufacturing expertise and support.
May 16, 2018
The company is increasing its cell culture media production capacity at its facilities in Pasching, Austria, and Logan, Utah.
Valerius Biopharma will use Catalent’s GPEx technology to produce cell lines for biosimilar drugs.
May 15, 2018
Understanding the advantages and suitability of different methods to measure residual moisture content in lyophilized materials--and the respective limitations--aids in selecting the most appropriate method for testing.
Naturally occurring and engineered albumins are being explored as a tool to enhance the stability of drugs, including biologics, and extend shelf-life.
May 02, 2018
A skilled workforce is needed to deliver on technology’s promising medical advances.
Bioprocess understanding, the right equipment, and automation help, but multifunctional teamwork is the key to API production success.
April 30, 2018
After a review of public comments, USP will not move forward with nomenclature proposal without further FDA collaboration.
April 20, 2018
The new platform is expected to speed up cell line development.
April 19, 2018
Johnson & Johnson’s Janssen partners with Bristol-Myers Squibb to advance next-generation therapies for cardiovascular diseases.